The Chemours Company
CC
$16.91
-$1.09-6.03%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.43% | 0.02% | 0.60% | -1.95% | -4.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.43% | 0.02% | 0.60% | -1.95% | -4.85% |
| Cost of Revenue | 5.60% | 2.55% | 1.92% | 0.26% | -2.77% |
| Gross Profit | -20.56% | -10.50% | -4.91% | -10.39% | -12.48% |
| SG&A Expenses | -14.31% | 3.42% | 8.81% | -2.03% | 2.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.26% | 2.55% | 2.63% | -0.04% | -2.12% |
| Operating Income | -33.86% | -29.06% | -23.25% | -21.69% | -28.92% |
| Income Before Tax | -358.88% | -652.63% | -453.01% | 108.83% | 133.86% |
| Income Tax Expenses | 194.59% | 550.00% | 600.00% | 126.88% | 145.68% |
| Earnings from Continuing Operations | -651.43% | -609.09% | -489.09% | 103.68% | 129.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 50.00% | 50.00% | -- | -- |
| Net Income | -651.43% | -626.56% | -497.22% | 103.66% | 129.54% |
| EBIT | -33.86% | -29.06% | -23.25% | -21.69% | -28.92% |
| EBITDA | -13.80% | -15.53% | -12.92% | -13.90% | -20.95% |
| EPS Basic | -646.60% | -622.76% | -494.72% | 103.68% | 129.58% |
| Normalized Basic EPS | -71.61% | -57.30% | -48.59% | -43.86% | -50.01% |
| EPS Diluted | -673.77% | -662.61% | -509.96% | 102.71% | 127.91% |
| Normalized Diluted EPS | -71.57% | -57.21% | -48.26% | -43.77% | -49.81% |
| Average Basic Shares Outstanding | 0.50% | 0.55% | 0.63% | 0.54% | 0.40% |
| Average Diluted Shares Outstanding | 0.28% | 0.34% | 0.08% | 0.23% | 0.06% |
| Dividend Per Share | -48.75% | -32.50% | -16.25% | 0.00% | 0.00% |
| Payout Ratio | -1.10% | -1.13% | -1.21% | 28.15% | 4.36% |